Matthew K. Fust - Director at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ATRA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew K. Fust since 11/5/2023

Holdings reported by Matthew K. Fust for Atara Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 259K $186K $0.72 Mar 31, 2024 Direct
Non-Qualified Stock Option (Right to Buy) 79.5K May 31, 2023 Direct Common Stock

Transactions reported by Matthew K. Fust for Atara Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.